Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josh DeClercq

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Multiple Sclerosis and Related Disorders|May 24, 2022
A cross-sectional analysis of persistence to disease-modifying therapies in treatment naïve and experienced patients with relapsing multiple sclerosis at a health-system specialty pharmacyMiranda Z Kozlicki, Brandon Markley, Nisha B Shah, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 8, 2022
Prescription cannabidiol for seizure disorder management: Initial drug-drug interaction management by specialty pharmacistsHolly Dial, Wendi Owens, Josh DeClercq, et al.
Journal of Huntington'S Disease|February 19, 2016
Huntington's Disease Protein Huntingtin Associates with its own mRNABrady P Culver, Josh DeClercq, Igor Dolgalev, et al.
Journal of Managed Care & Specialty Pharmacy|January 28, 2021
Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health-system specialty pharmacyMegan E Peter, Brandon Markley, Josh DeClercq, et al.
Journal of the American Pharmacists Association : Japha|August 19, 2022
Specialty pharmacy integration and the role of an advanced certified pharmacy technician in prescription cannabidiol accessWendi Owens, Holly Dial, Josh DeClercq, et al.
Journal of the American Pharmacists Association : Japha|July 5, 2022
Droxidopa management by an integrated health-system specialty pharmacy teamSabrina N Livezey, Nisha B Shah, Josh DeClercq, et al.
Journal of the American Pharmacists Association : Japha|August 3, 2021
Integrating pharmacists into a kidney transplant clinic: Developing and implementing a collaborative pharmacy practice agreementKeren E Rodriguez, Rachel J Chelewski, Megan E Peter, et al.
Journal of Managed Care & Specialty Pharmacy|July 1, 2024
Evaluating patient-reported adherence and outcomes in specialty disease states: A dual-site initiativeE Danielle Bryan, Chelsea P Renfro, Rebekah H Anguiano, et al.
Epilepsy & Behavior : E&B|September 4, 2023
Therapy outcomes associated with prescription cannabidiol use at 12 months post-initiationKayla Johnson, Jessica P Barnes, Holly Dial, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 23, 2025
Pharmacist tailored monitoring for patients initiating encorafenib and binimetinib combination therapyBrooke D Looney, Stephanie G White, Josh DeClercq, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Multiple Sclerosis and Related Disorders|May 24, 2022
A cross-sectional analysis of persistence to disease-modifying therapies in treatment naïve and experienced patients with relapsing multiple sclerosis at a health-system specialty pharmacyMiranda Z Kozlicki, Brandon Markley, Nisha B Shah, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 8, 2022
Prescription cannabidiol for seizure disorder management: Initial drug-drug interaction management by specialty pharmacistsHolly Dial, Wendi Owens, Josh DeClercq, et al.
Journal of Huntington'S Disease|February 19, 2016
Huntington's Disease Protein Huntingtin Associates with its own mRNABrady P Culver, Josh DeClercq, Igor Dolgalev, et al.
Journal of Managed Care & Specialty Pharmacy|January 28, 2021
Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health-system specialty pharmacyMegan E Peter, Brandon Markley, Josh DeClercq, et al.
Journal of the American Pharmacists Association : Japha|August 19, 2022
Specialty pharmacy integration and the role of an advanced certified pharmacy technician in prescription cannabidiol accessWendi Owens, Holly Dial, Josh DeClercq, et al.
Journal of the American Pharmacists Association : Japha|July 5, 2022
Droxidopa management by an integrated health-system specialty pharmacy teamSabrina N Livezey, Nisha B Shah, Josh DeClercq, et al.
Journal of the American Pharmacists Association : Japha|August 3, 2021
Integrating pharmacists into a kidney transplant clinic: Developing and implementing a collaborative pharmacy practice agreementKeren E Rodriguez, Rachel J Chelewski, Megan E Peter, et al.
Journal of Managed Care & Specialty Pharmacy|July 1, 2024
Evaluating patient-reported adherence and outcomes in specialty disease states: A dual-site initiativeE Danielle Bryan, Chelsea P Renfro, Rebekah H Anguiano, et al.
Epilepsy & Behavior : E&B|September 4, 2023
Therapy outcomes associated with prescription cannabidiol use at 12 months post-initiationKayla Johnson, Jessica P Barnes, Holly Dial, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 23, 2025
Pharmacist tailored monitoring for patients initiating encorafenib and binimetinib combination therapyBrooke D Looney, Stephanie G White, Josh DeClercq, et al.
Pageof 6